Brain Cancer - news item 1 of 35
|
|
Thallion pharmaceuticals inc.: thallion receives health canada approval to initiate phase ii for tln-4601 in brain cancer
|
|
MONTREAL, QUEBEC (MARKET WIRE) Thallion Pharmaceuticals Inc. (TSX: TLN) today announced it has received authorization from the Therapeutic Products Directorate of Health Canada to initiate a Phase II clinical trial evaluating TLN-4601 as a monotherapy treatment for patients with glioblastoma multiforme (GBM), an advanced form of brain cancer, as a...
|
|
RSS Source: Med Worm - Brain Cancer Mon, 12 May 2008 6:19:00 pm
|
|
|
|
Brain Cancer - news item 2 of 35
|
|
Bipar sciences expands phase 2 clinical trials of bsi-201, a novel dna repair inhibitor, in ovarian cancer
|
|
BiPar Sciences, Inc. announced the expansion of Phase 2 clinical trial programs for its lead product, BSI-201, in ovarian cancer. This is the third major clinical trial of BSI-201 that BiPar has launched in the past 6 months, expanding on on going trials in breast and brain cancer. (Source: Cancer /...
|
|
RSS Source: Med Worm - Brain Cancer Fri, 9 May 2008 7:00:00 am
|
|
|
|
Brain Cancer - news item 3 of 35
|
|
Experimental vaccine offers hope against brain cancer
|
|
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
|
|
RSS Source: Med Worm - Brain Cancer Wed, 7 May 2008 5:21:27 pm
|
|
|
|
Brain Cancer - news item 4 of 35
|
|
The postoperative brain tumour stem cell (btsc) niche and cancer recurrence.
|
|
Related Articles The postoperative brain tumour stem cell (BTSC) niche and cancer recurrence. Adv Ther. 2008 May 7; Authors: Liu JM, Mao BY, Hong S, Liu YH, Wang XJ Currently, surgical resection is one of only a few options for treating brain cancer. Unfortunately, postoperative tumour recurrence remains almost inevitable...
|
|
RSS Source: Med Worm - Brain Cancer Wed, 7 May 2008 4:00:00 am
|
|
|
|
Brain Cancer - news item 5 of 35
|
|
Canadian-born doctor's vaccine fights brain cancer
|
|
It's a type of aggressive and incurable brain cancer that strikes about 20,000 people a year, but a Canadian-born scientist is working on a vaccine - and the early results are promising. (Source: CTV Health)
|
|
RSS Source: Med Worm - Brain Cancer Mon, 5 May 2008 6:37:37 am
|
|
|
|
Brain Cancer - news item 6 of 35
|
|
Work exposure to weed killers tied to brain cancer
|
|
NEW YORK (Reuters Health) - Women whose jobs regularly expose them to weed killers may have a higher-than-normal risk of a particular form of brain cancer, results of a U.S. study suggest. (Source: Reuters: Health)
|
|
RSS Source: Med Worm - Brain Cancer Fri, 2 May 2008 5:03:03 pm
|
|
|
|
Brain Cancer - news item 7 of 35
|
|
Depression worsens brain cancer outcomes
|
|
People who are suffering from depression are significantly less likely to survive the most common form of brain cancer. (Source: Medical Headlines From Ivanhoe.com)
|
|
RSS Source: Med Worm - Brain Cancer Thu, 1 May 2008 5:00:00 am
|
|
|
|
Brain Cancer - news item 8 of 35
|
|
Therapy uses immune system to fight brain tumors
|
|
CHICAGO (Reuters) - U.S. researchers are targeting a deadly brain cancer by taking aim at a common virus active in most people with these tumors. (Source: Reuters: Health)
|
|
RSS Source: Med Worm - Brain Cancer Mon, 28 Apr 2008 10:42:08 pm
|
|
|
|
Brain Cancer - news item 9 of 35
|
|
Cancer mortality in ibm endicott plant workers, 1969-2001: an update on a ny production plant
|
|
Background: In response to concerns expressed by workers at a public meeting, we analyzed the mortality experience of workers who were employed at the IBM plant in Endicott, New York and died between 1969-2001. An epidemiologic feasibility assessment indicated potential worker exposure to several known and suspected carcinogens at this...
|
|
RSS Source: Med Worm - Brain Cancer Mon, 28 Apr 2008 4:00:00 am
|
|
|
|
Brain Cancer - news item 10 of 35
|
|
Demystifying medicine - brain cancer: problems and progress
|
|
Demystifying Medicine - Brain Cancer: Problems and ProgressPresented by: Howard Fine (NCI) and colleaguesCategory: Demystifying MedicineAired date: 04/22/2008 (Source: Videocast - All Events)
|
|
RSS Source: Med Worm - Brain Cancer Thu, 24 Apr 2008 7:25:00 pm
|
|
|
|
Brain Cancer - news item 11 of 35
|
|
Patient trial for virus that attacks brain cancer cells
|
|
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
|
|
RSS Source: Med Worm - Brain Cancer Tue, 22 Apr 2008 3:11:45 am
|
|
|
|
Brain Cancer - news item 12 of 35
|
|
Research suggests breathing in pollution could trigger brain cancer
|
|
Dr. Julia Ljubimova found something disturbing when she probed the brains of rats exposed to air pollution: The dirty air appeared to trigger changes indicating the earliest stage of brain tumors. (Source: Knoxville News Sentinel: Health and fitness)
|
|
RSS Source: Med Worm - Brain Cancer Mon, 21 Apr 2008 4:00:50 am
|
|
|
|
Brain Cancer - news item 13 of 35
|
|
Cedars-sinai medical center opens patient trial of virus that attacks brain cancer cells
|
|
A common, naturally occurring virus that attacks cancer cells but appears to be harmless to normal cells is being studied as a possible treatment for malignant, highly aggressive and deadly brain tumors called gliomas. Researchers at Cedars-Sinai Medical Center are among a few in the United States evaluating this experimental...
|
|
RSS Source: Med Worm - Brain Cancer Fri, 18 Apr 2008 8:00:00 am
|
|
|
|
Brain Cancer - news item 14 of 35
|
|
Avant, pfizer sign $50m cancer vaccine deal
|
|
Avant Immunotherapeutics Inc. will make at least $50 million thanks to a development deal signed with Pfizer Inc. for a potential brain cancer treatment. (PFE) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
|
|
RSS Source: Med Worm - Brain Cancer Thu, 17 Apr 2008 7:29:04 pm
|
|
|
|
Brain Cancer - news item 15 of 35
|
|
Pfizer license of avant brain-cancer drug worth potential $440m
|
|
Avant Immunotherapeutics Inc. has agreed to license its vaccine for brain cancer to drug giant Pfizer Inc. for an initial sum of $40 million, the companies report. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
|
|
RSS Source: Med Worm - Brain Cancer Thu, 17 Apr 2008 3:01:49 pm
|
|
|
|
Brain Cancer - news item 16 of 35
|
|
Pfizer and avant enter into licensing and development agreement for novel therapeutic vaccine candidate for brain cancer
|
|
NEW YORK & NEEDHAM, Mass.--(BUSINESS WIRE)--Apr 16, 2008 - Pfizer, Inc (NYSE: PFE) and AVANT Immunotherapeutics (Nasdaq: AVAN), acting through its wholly-owned subsidiary Celldex Therapeutics, Inc. today announced that they have entered into... (Source: Drugs.com - Pharma News)
|
|
RSS Source: Med Worm - Brain Cancer Thu, 17 Apr 2008 12:45:11 pm
|
|
|
|
Brain Cancer - news item 17 of 35
|
|
How new technologies could help doctors predict patient outcomes
|
|
As potential cancer therapies proliferate, researchers and clinicians are striving to measure their effectiveness and to more accurately predict which patients will receive the most benefit. At the American Association for Cancer Research 2008 Annual Meeting, April 12-16, 2008, researchers presented data on a new role for MRI in brain...
|
|
RSS Source: Med Worm - Brain Cancer Thu, 17 Apr 2008 11:00:00 am
|
|
|
|
Brain Cancer - news item 18 of 35
|
|
Sangamo biosciences announces presentation of data on zfp therapeutic for glioblastoma at american association for cancer research (aacr)
|
|
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the presentation of positive data in a mouse tumor model from its ZFP Therapeutic(TM) program for the treatment of glioblastoma multiforme (GBM), a progressive and usually fatal brain cancer. The data were presented in the New Approaches to Biological Therapy Session at the 2008...
|
|
RSS Source: Med Worm - Brain Cancer Thu, 17 Apr 2008 7:00:00 am
|
|
|
|
Brain Cancer - news item 19 of 35
|
|
Drugs in the pipeline: new therapies that could change treatment strategies
|
|
The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients with a relatively common, aggressive type of brain cancer, according to results from a clinical trial conducted by Boston researchers. (Source: News-Medical News Feed)
|
|
RSS Source: Med Worm - Brain Cancer Thu, 17 Apr 2008 3:11:00 am
|
|
|
|
Brain Cancer - news item 20 of 35
|
|
Oncolin therapeutics announces its lead technology has shown to be effective in treating cancer in animal models
|
|
Oncolin Therapeutics, Inc., (OTCBB:OCOL) (Oncolin) announces that one of its lead drug candidates has shown in preclinical testing that it extends the life of animals that have human tumors implanted in their brains. The early testing has yielded results in animals that are equivalent to that of Temodar®, which is...
|
|
RSS Source: Med Worm - Brain Cancer Wed, 16 Apr 2008 11:00:00 am
|
|
|
|
Brain Cancer - news item 21 of 35
|
|
Measuring medicine: how new technologies could help doctors predict patient outcomes
|
|
As potential cancer therapies proliferate, researchers and clinicians are striving to measure their effectiveness and to more accurately predict which patients will receive the most benefit. At the American Association for Cancer Research 2008 Annual Meeting, April 12-16, 2008, researchers present data on a new role for MRI in brain...
|
|
RSS Source: Med Worm - Brain Cancer Wed, 16 Apr 2008 4:00:00 am
|
|
|
|
Brain Cancer - news item 22 of 35
|
|
Residential magnetic field exposure and childhood brain cancer: a meta-analysis.
|
|
Page: 424DOI: 10.1097/EDE.0b013e3181690715Authors: Mezei, Gabor a; Gadallah, May b; Kheifets, Leeka b (Source: Epidemiology)
|
|
RSS Source: Med Worm - Brain Cancer Tue, 15 Apr 2008 7:44:20 am
|
|
|
|
Brain Cancer - news item 23 of 35
|
|
Tumor gene predicted whether children have severe brain cancer
|
|
(Source: Health Behavior News Digest)
|
|
RSS Source: Med Worm - Brain Cancer Mon, 14 Apr 2008 6:45:41 pm
|
|
|
|
Brain Cancer - news item 24 of 35
|
|
Turning to the immune system to fight malignant glioma: upci researchers present novel findings at aacr annual meeting
|
|
Mitsugu Fujita, M.D., Ph.D., and Ryo Ueda, M.D., Ph.D., both researchers with the University of Pittsburgh Cancer Institute's (UPCI) Brain Tumor Program, are pursuing the same aim: understanding the body's immune system in order to fight the deadliest and most common form of brain cancer. At the American Association for...
|
|
RSS Source: Med Worm - Brain Cancer Mon, 14 Apr 2008 6:00:00 pm
|
|
|
|
Brain Cancer - news item 25 of 35
|
|
How i'm juggling being one of our youngest brain surgeons and a new mum
|
|
Gelareh Zadeh is one of Britain's youngest brain surgeons, and in her special field of brain cancer treatment she is among the most brilliant. But she is also one of the world's few female brain surgeons - and in December she gave birth to her first child (Source: the Mail...
|
|
RSS Source: Med Worm - Brain Cancer Sun, 13 Apr 2008 7:13:39 am
|
|
|
|
Brain Cancer - news item 26 of 35
|
|
Bipar sciences expands clinical program for bsi-201, a novel dna repair inhibitor, in brain cancer
|
|
BiPar Sciences, Inc. announced the expansion of the clinical program for the company's lead product candidate, BSI-201, into glioblastoma multiforme (GBM), the most common glioma in adults. BSI-201, the first poly ADP-ribose polymerase (PARP) inhibitor in BiPar's DNA repair portfolio, crosses the blood-brain barrier, a unique property that enables its...
|
|
RSS Source: Med Worm - Brain Cancer Fri, 11 Apr 2008 7:00:00 am
|
|
|
|
Brain Cancer - news item 27 of 35
|
|
Occupational exposure to pesticides and risk of adult brain tumors
|
|
The authors examined incident glioma and meningioma risk associated with occupational exposure to insecticides and herbicides in a hospital-based, case-control study of brain cancer. Cases were 462 glioma and 195 meningioma patients diagnosed between 1994 and 1998 in three US hospitals. Controls were 765 patients admitted to the same hospitals...
|
|
RSS Source: Med Worm - Brain Cancer Fri, 11 Apr 2008 4:00:00 am
|
|
|
|
Brain Cancer - news item 28 of 35
|
|
New regulatory circuit identified for aggressive, malignant brain tumor
|
|
Researchers have developed a new algorithm for ranking abnormal genes according to their likelihood of contributing to a cancer. They also show that a gene identified by the algorithm as a likely restrainer of tumor growth does indeed play that role in a common type of brain cancer, and is...
|
|
RSS Source: Med Worm - Brain Cancer Thu, 10 Apr 2008 6:00:00 am
|
|
|
|
Brain Cancer - news item 29 of 35
|
|
Data-handling technique finds genes to be team players in curbing brain cancer cell growth
|
|
The search for cancer genes is increasingly a matter of molecular "To Tell the Truth," as scientists seek to distinguish genes actually involved in the disease from those that are imposters. Powerful gene-scanning technology often reveals hundreds or thousands of genetic irregularities in tumor tissue, making it critical for investigators...
|
|
RSS Source: Med Worm - Brain Cancer Tue, 8 Apr 2008 3:00:00 pm
|
|
|
|
Brain Cancer - news item 30 of 35
|
|
Unlocking the mysteries of brain cancer, stroke is focus of new research
|
|
New studies at the University of Adelaide will delve into some of the crucial issues surrounding death by brain tumours and stroke.The research, to be conducted in the joint University of Adelaide/IMVS Centre for Neurological Diseases, will aim to find links between chemical signals in the brain and the reasons...
|
|
RSS Source: Med Worm - Brain Cancer Mon, 7 Apr 2008 7:00:00 am
|
|
|
|
Brain Cancer - news item 31 of 35
|
|
Targeting brain cancer
|
|
You hear the words brain cancer and you say -- it could never happen to me. (Source: Medical Headlines From Ivanhoe.com)
|
|
RSS Source: Med Worm - Brain Cancer Fri, 4 Apr 2008 5:00:00 am
|
|
|
|
Brain Cancer - news item 32 of 35
|
|
Top neurosurgeon warns of brain cancer risk with mobile phones
|
|
One of Australia's leading neurosurgeons has warned about the heavy reliance on mobile phones in today's society. (Source: News-Medical News Feed)
|
|
RSS Source: Med Worm - Brain Cancer Mon, 31 Mar 2008 9:22:13 am
|
|
|
|
Brain Cancer - news item 33 of 35
|
|
Veterinary college researcher studying brain tumors in people and animals
|
|
Gliomas are an aggressive form of brain cancer that affects dogs and people. To develop more precise systems for administering therapeutic agents to cancer cells, veterinary researchers are attempting to further establish the molecular similarity of human and canine gliomas. The Center for Comparative Oncology at Virginia Tech has opened...
|
|
RSS Source: Med Worm - Brain Cancer Mon, 31 Mar 2008 4:00:00 am
|
|
|
|
Brain Cancer - news item 34 of 35
|
|
Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment
|
|
Brain Pathology, Volume 0, Issue 0, Page ???, OnlineEarly Articles. Abstract All patients with glioblastoma, the most aggressive and common form of brain cancer, develop cerebral edema. This complication is routinely treated with dexamethasone, a steroidal anti-inflammatory drug whose effects on brain tumors are not ... (Source: Brain Pathology)
|
|
RSS Source: Med Worm - Brain Cancer Fri, 28 Mar 2008 4:21:32 am
|
|
|
|
Brain Cancer - news item 35 of 35
|
|
Re: "radio-frequency radiation exposure from am radio transmitters and childhood leukemia and brain cancer"
|
|
(Source: American Journal of Epidemiology)
|
|
RSS Source: Med Worm - Brain Cancer Fri, 28 Mar 2008 4:00:00 am
|
|
|